Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 16/20 | 0.60 |
| ▸ | PPARG | P37231 | 11/20 | 0.53 |
| ▸ | PPARD | Q03181 | 5/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7551490 | 0.92 | PPARA (0.60) | PPARAPPARGPPARDFFAR1PTPN1 | |
| SCHEMBL7548625 | 0.87 | PPARA (0.55) | PPARAPPARGPPARDFFAR1MAOB | |
| SCHEMBL7556358 | 0.82 | PTPN1 (0.47) | PPARAPPARGPPARDPTPN1MAOB | |
| SCHEMBL7070013 | 0.81 | PPARA (0.67) | PPARAPPARGPPARD | |
| SCHEMBL7551266 | 0.78 | MAOB (0.58) | PPARAPPARGPPARDMAOBMAOA | |
| SCHEMBL7556111 | 0.78 | PPARG (0.58) | PPARAPPARGPTPN1MAOB | |
| SCHEMBL7549067 | 0.77 | MAOB (0.47) | PPARAPPARGPPARDPTPN1MAOB | |
| SCHEMBL7069280 | 0.77 | PPARG (0.54) | PPARAPPARGPPARDMAOB | |
| SCHEMBL7070373 | 0.76 | PPARA (0.67) | PPARAPPARGPPARD | |
| SCHEMBL7551042 | 0.75 | PPARA (0.40) | PPARAPPARGPPARDFFAR1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020032330-A1 | Propionic acid derivatives | NOMURA YUTAKA (JP) | 2002-03-14 | — | — | US | disclosed |
| EP-0994095-A1 | PROPIONIC ACID DERIVATIVES | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032330-A1 | Propionic acid derivatives | ABAT, ACAT1, PDXK | PPARA 56/4885PPARG 123/4885PPARD 198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.